Silodosin is used for: Treating the signs and symptoms of enlarged prostate (benign prostatic hyperplasia [BPH]).
Recorded in the NepalDoc medicine catalog for Silodosin.
Silodosin capsules, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
From the U.S. FDA-approved label for Silodosin. Full label: DailyMed.
Silodosin capsules, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
From the U.S. FDA-approved label for Silodosin. Full label: DailyMed.
8 mg capsules taken orally once daily with a meal. 4 mg capsules taken orally once daily with a meal for those with moderate renal impairment. 2.1 Dosing Information The recommended dose is 8 mg orally once daily with a meal.
Directions from the U.S. FDA-approved label for Silodosin — your doctor or pharmacist may advise differently.
Patients with severe renal impairment. Patients with severe hepatic impairment (Child-Pugh score ≥ 10). Concomitant administration with strong Cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir). Patients with a history of hypersensitivity to silodosin or any of the ingredients of silodosin capsules.
Excerpt from the U.S. FDA-approved label for Silodosin. Talk to a pharmacist or doctor before use.
Postural hypotension, with or without symptoms (e.g., dizziness), may develop when beginning silodosin treatment. In patients with moderate renal impairment, silodosin dose should be reduced to 4 mg once daily. Silodosin should not be used in combination with other alpha-blockers. Examine patients thought to have BPH prior to starting therapy with silodosin to rule out the presence of carcinoma of the prostate. Inform patients planning cataract surgery to notify their ophthalmologist that they are taking silodosin because of the possibility of Intraoperative Floppy Iris Syndrome (IFIS).
Warnings and precautions excerpt from the U.S. FDA-approved label for Silodosin — not a complete list. Talk to a pharmacist or doctor before use.
Most common adverse reactions (incidence ≥ 2%) are retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, and nasal congestion. To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at 1-800-399-2561 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Silodosin — not a complete list. Talk to a pharmacist or doctor about side effects.
3 brands · 2 makers in the NepalDoc catalog — see the full Silodosin guide →
Storage Store at 25°C (77°F); Protect from light and moisture. Keep out of reach of children.
Storage information from the U.S. FDA-approved label for Silodosin.
What is SILOSIN?
SILOSIN 8MG Capsule is a Silodosin medicine made by Asian Pharmaceuticals Pvt. Ltd. It comes as 8MG Capsule.
What is SILOSIN used for?
Silodosin is used for Treating the signs and symptoms of enlarged prostate (benign prostatic hyperplasia [BPH]).
What is the generic name of SILOSIN?
The generic name of SILOSIN is Silodosin.
Which brands of Silodosin are available in Nepal?
3 brands of Silodosin are listed in the NepalDoc catalog, from 2 makers — including Silosin 4MG Capsule, URADER 8MG Capsule.
What are the side effects of Silodosin?
Most common adverse reactions (incidence ≥ 2%) are retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, and nasal congestion. To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
